Navigation Links
Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June
Date:4/9/2008

cur at any stage of testing. The Company does not know whether its Phase 3 registration trial or any future clinical trials will demonstrate safety and efficacy sufficient to result in marketable products. Favrille's failure to adequately demonstrate the safety and efficacy of Specifid will prevent the Company from obtaining regulatory approval for, or commercializing, Specifid.

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Favrille's product candidates, proprietary technologies and research and clinical development programs. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Favrille's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to, risks and uncertainties related to progress and timing of clinical trials for Specifid, including difficulties or delays in development, testing, manufacturing and marketing Specifid or Favrille's other product candidates; delays in the availability of data from Favrille's Phase 3 clinical trial; Favrille's ability to obtain marketing approval for Specifid or Favrille's other product candidates and the timing of any such approvals, including whether it will receive expedited review as a result of the Fast Track designation; Favrille's ability to manufacture sufficient quantities of Specifid for use in clinical trials and, if Specifid receives marketing approval, for commercialization; risks associated with achieving projected operating metrics and financial performance or the anticipated number of patients using Specifid; Favrille's ability to obtain additional financing to support its operations; and additional risks discussed in Favrille's filings with the Securities and Exchange Commission. In ad
'/>"/>

SOURCE Favrille, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
2. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
3. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
4. Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment
5. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
6. Medarex Announces Ipilimumab Program Continues to Move Forward
7. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
8. CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors
9. ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
10. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
11. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... (NYSE: RMD ), a pioneer and innovator in ... sleep apnea solutions specifically for women, is launching a new ... night,s sleep. The Better Sleep For Women ... just part of living a busy life. It will encourage ... health, essential to not only living an active lifestyle but ...
(Date:10/1/2014)... Oct. 1, 2014 NeuroCall, Inc., ("NeuroCall") announced ... its Telestroke and Teleneurology services. Dr. Ricardo Garcia-Rivera ... "We are extremely proud that our quality of service ... continue to provide lifesaving support and continuity of care ... throughout the United States ." ...
(Date:10/1/2014)...  Varian Medical Systems (NYSE: VAR ) ... fourth quarter of fiscal year 2014 following the close ... news release will be followed by a teleconference available ... news release and a link to the conference call ... www.varian.com/investor .  To access the teleconference call and ...
Breaking Medicine Technology:ResMed Launches Initiative to Help Women Get Better Sleep 2ResMed Launches Initiative to Help Women Get Better Sleep 3NeuroCall Awarded Joint Commission Accreditation 2Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2
... 10, 2010 Nycomed US Inc. announced today the ... Vice President and General Counsel, reporting to Steve Andrzejewski, ... legal advisor of the company and oversee all of ... he will also be responsible for the company,s compliance ...
... ULURU Inc. (NYSE Amex: ULU ) today provided ... care conferences. During the past 45 days Altrazeal® has ... of Advanced Wound Care ("SAWC") Clinical Symposium on Advances in ... Participation in these conferences not only benefit our ...
Cached Medicine Technology:Joseph J. LaRosa Joins Nycomed US Inc. 2ULURU Inc. Provides Altrazeal® Clinical Update 2ULURU Inc. Provides Altrazeal® Clinical Update 3ULURU Inc. Provides Altrazeal® Clinical Update 4
(Date:10/1/2014)... (PRWEB) October 01, 2014 Between 23 ... in the U.S., according to figures from the National ... Diseases Association (AARDA), and many of them have something ... of having undiagnosed celiac disease. Gluten Free Therapeutics, ... awareness of undiagnosed celiac disease by publishing a series ...
(Date:10/1/2014)... 01, 2014 Diet Doc understands that many ... lose weight and their dieting attempts could be easily sabotaged ... hormone diet treatments into their programs as a ... see fast and effective weight loss results, it also allows ... habits to maintain their weight for the future. , Earlier ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Anti Aging ... and skin rejuvenating destination of choice, is announcing a ... October through to December. , “We’re doing this because ... possible to our top skin clinic in Toronto,” says ... do so much at Anti Aging Clinic, including laser ...
(Date:10/1/2014)... On Sept. 9, Chapín Coffee was selected ... Stewart American Made Awards (MSAMAs), an annual competition in ... the fields of crafts, design, food and style. ... in the MSAMAs, which celebrates entrepreneurs and artisans who ... communities and changing the way we shop, work and ...
(Date:10/1/2014)... 2014 Nordic Naturals is kicking ... special cause. The campaign—“Buy One Bottle. Help Two ... Veterans, a nonprofit organization that helps rebuild the ... dogs that would otherwise face euthanasia. From October ... support monthly donations of Nordic Naturals omega-3s to ...
Breaking Medicine News(10 mins):Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2Health News:Chicago Coffee Start-up Makes a Big Impact, Earns National Recognition 2Health News:Nordic Naturals® Inspires Support for Paws for Veterans -- ‘Buy One Bottle. Help Two Heroes.’ Initiative Kicks Off October 1 2
... , , , SEATTLE, July 17 ... by exacerbating conditions like hypertension, stress and fatigue, but also by causing people ... , Physicians at The Polyclinic in Seattle are offering suggestions for ... health. , , Don, t put ...
... , WASHINGTON, July 17 The Association ... Director of Policy and Public Affairs, in response to the AMA,s endorsement ... American Medical Association has sold out patients and the profession by endorsing ... "Why did the AMA do it? For a few dollars increase ...
... , , , ... (Nasdaq: NGSX ) announced today that Bruce A. Peacock has ... on his responsibilities as CEO of privately-held Alba Therapeutics. , ... no opportune time to resign, I feel confident that NeurogesX is well ...
... and avoided vitamin B deficiency , FRIDAY, July ... gastric bypass surgery helps patients lose weight faster and ... Probiotics are the "good" bacteria found in yogurt and ... University School of Medicine study included 44 patients who ...
... , CAMBRIDGE, Mass., July 17 Biopure Corporation ... The Nasdaq Stock Market, by letter dated July 17, 2009, that its ... because of concerns raised by the Company,s filing for protection under Chapter ... of business on July 28, 2009. , , ...
... , Cabinet Secretaries Kathleen Sebelius, Hilda L. ... community forum and hold m edi ... WASHINGTON , July 17 U.S. Department of ... U.S. Department of Agriculture Secretary Tom Vilsack and U.S. Department of Veterans Affairs Secretary Eric ...
Cached Medicine News:Health News:How to Afford Health Care in Hard Times 2Health News:Doctors: AMA Has Sold Out Patients & the Profession For A Few Dollars 2Health News:NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors 2Health News:NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors 3Health News:NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors 4Health News:Top Obama administration officials to hold rural health community forum 2
Inquire...
Microseal 'F' foil, seals plates for cold storage (or cycling >25l), disposable, pkg of 100...
Sterilization: sterilized Yes...
Effective adhesive, may be removed from plate without residue. Transparent film for easy visual monitoring of samples...
Medicine Products: